SCHEMBL3289486

SCHEMBL3289486

C=CCc1cc(OC)c2c(c1OCc1ccccc1)[C@H]1CC[C@@H]2C1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
BCHE P06276 10/20 0.42
TDP1 Q9NUW8 2/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HTT P42858 1/20 0.39
ALOX15 P16050 1/20 0.39
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3289482 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTL3MBTL1CYP3A4
SCHEMBL3294950 0.95 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTL3MBTL1CYP3A4
SCHEMBL3290680 0.76 MGAM (0.39) KDM4EL3MBTL1CYP1A2BCHETDP1
SCHEMBL3292068 0.75 CYP3A4 (0.43) ALDH1A1KDM4EMAPTCYP3A4HPGD
SCHEMBL3292072 0.75 CYP3A4 (0.43) ALDH1A1KDM4EMAPTCYP3A4HPGD
SCHEMBL4234474 0.74 BCHE (0.65) KDM4EL3MBTL1BCHE
SCHEMBL19490990 0.73 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTL3MBTL1CYP3A4
SCHEMBL3291010 0.73 ALDH1A1 (0.63) ALDH1A1KDM4EMAPTL3MBTL1CYP3A4
SCHEMBL3292946 0.72 GAA (0.34) ALDH1A1KDM4EGAAHPGDMEN1
SCHEMBL3292942 0.72 GAA (0.34) ALDH1A1KDM4EGAAHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728155-B2 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents WYETH LLC (US) 2010-06-01 US disclosed
US-20050124692-A1 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents WYETH (US) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124692-A1 Dihydrobenzofuranyl alkanamines and methods for using same as cns agents HTR2C, HTR1A, HTR1B ALDH1A1 185/4885KDM4E 2343/4885MAPT 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.